Switching factor products: selecting patients and managing the process

Clotting factor concentrates used in the treatment of haemophilia are now procured centrally in the UK by nationally organised competitive tendering to obtain the best product price while still preserving some degree of prescribing freedom. Inevitably, however, some patients are required to switch f...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Haemophilia Practice 2018-04, Vol.1 (2), p.24-29
Hauptverfasser:	Harrington, Christine, Hay, Charles, Vidler, Vicky, Dattani, Rashesh, Heygate, Katherine
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!